| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $19,898,475 ) (Continued on the next page) |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | K23AI163343 | Cytomegalovirus-specific Immune Reconstitution after Hematopoietic Cell Transplantation in the Era of Modern Antiviral Prophylaxis | 001 | 7 | NIH | 1/26/2026 | $187,540 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R35GM156316 | Protein arginine methylation in transcription and RNA metabolism | 000 | 2 | NIH | 1/22/2026 | $400,500 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R35GM156498 | Emergent role of allostery on function of GPCRs and Trimeric G proteins | 001 | 2 | NIH | 1/22/2026 | $400,500 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R03DE034794 | Protein Phosphoribosylation: Characterization of a novel protein modification | 000 | 2 | NIH | 3/5/2026 | $178,000 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA258981 | The Role of miR-142 in the Transformation of Clonal Hematopoietic Disorders into AML | 000 | 5 | NIH | 12/22/2025 | $488,601 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01HL173308 | Novel mechanisms and therapeutics for Tyrosine Kinase Inhibitor-induced Cardiotoxicity | 001 | 2 | NIH | 3/20/2026 | $21,701 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R35GM156498 | Emergent role of allostery on function of GPCRs and Trimeric G proteins | 002 | 2 | NIH | 3/10/2026 | $44,500 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA292596 | Anti-CD38 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Myelogenous Leukemia | 001 | 2 | NIH | 3/3/2026 | $738,698 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA292893 | Targeting AMP Synthesis to Overcome Resistance to BH3 Mimetics in Acute Myeloid Leukemia | 000 | 2 | NIH | 2/27/2026 | $713,836 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R21AI196968 | Molecular Mechanisms Governing Non-canonical miR-146a Biogenesis | 000 | 1 | NIH | 2/5/2026 | $489,500 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01NS138604 | High Fidelity Genome Editing for the Correction of MECP2 Mutations and Physiologic Regulation of Expression in Rett Syndrome | 000 | 2 | NIH | 2/25/2026 | $718,682 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01HL173308 | Novel mechanisms and therapeutics for Tyrosine Kinase Inhibitor-induced Cardiotoxicity | 000 | 2 | NIH | 2/23/2026 | $687,181 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01NS132083 | Biological function and regulation of PRMT9 in synapse development | 001 | 3 | NIH | 3/3/2026 | $59,488 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | T32CA186895 | DNA Damage Response and Oncogenic Signaling | 000 | 10 | NIH | 2/24/2026 | $239,954 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA297752 | Tumor-Selective Radiosensitization by Targeting Hypoxia in Rectal Cancer | 000 | 2 | NIH | 1/8/2026 | $578,672 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA279595 | Targeting Protein Arginine Methyltransferases to Eradicate Acute Myeloid Leukemia | 000 | 3 | NIH | 12/15/2025 | $637,252 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | P30CA033572 | Cancer Center Support Grant | 001 | 43 | NIH | 2/13/2026 | $3,612,130 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA258778 | Targeting tumor-associated macrophages for triple-negative breast cancer treatment | 000 | 5 | NIH | 12/11/2025 | $467,633 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | U01CA299594 | An exosome-based liquid biopsy assay for the non-invasive early detection of colorectal adenomas and cancers | 000 | 1 | NIH | 3/16/2026 | $738,675 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01DK141874 | DYRK1A inhibitors, GLP1 Receptor Agonists and Immunomodulation for Beta Cell Regeneration Therapy in Type 1 Diabetes | 000 | 1 | NIH | 2/16/2026 | $868,670 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA286160 | Targeting Immune Escape in CML/MPN Transformation | 000 | 3 | NIH | 12/12/2025 | $514,454 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01DK138665 | Targeting bile acid composition to treat metabolic diseases | 000 | 3 | NIH | 12/18/2025 | $665,898 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA269740 | Targeting the Microenvironment/Oncogene Cooperation to treat poor prognosis T-ALL | 000 | 4 | NIH | 2/18/2026 | $467,705 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA283171 | Attacking the Tumor Cell-Immune Milieu Interface to Overcome Richter's Transformation | 000 | 2 | NIH | 12/16/2025 | $632,001 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01DK134652 | Role of trefoil factor family proteins in beta cell function. | 000 | 4 | NIH | 12/5/2025 | $568,098 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA296280 | CMV-specific CD19 CAR T cells amplified in vivo using CMV Triplex vaccine for B-NHL | 000 | 2 | NIH | 12/10/2025 | $664,829 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA241845 | Validation of epigenomic biomarkers for thyroid cancer diagnostics | 000 | 5 | NIH | 12/10/2025 | $736,086 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA296394 | Targeting mitochondrial RNA methylation in high-risk acute myeloid leukemia | 000 | 2 | NIH | 12/10/2025 | $438,788 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA266665 | Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer | 001 | 5 | NIH | 1/28/2026 | $556,363 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R35GM156316 | Protein arginine methylation in transcription and RNA metabolism | 001 | 2 | NIH | 3/19/2026 | $44,500 |
| | 2026 | 2026 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01NS132083 | Biological function and regulation of PRMT9 in synapse development | 000 | 3 | NIH | 1/23/2026 | $535,402 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | P30CA033572 | Cancer Center Support Grant | 000 | 42 | NIH | 12/4/2025 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | DP5OD033424 | Biomarkers, mechanisms and modulation of oxidative stress associated risk factors in carcinogenesis | 000 | 4 | NIH | 12/15/2025 | -$88,999 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA259576 | The role of YTHDC1 in normal and malignant hematopoiesis | 001 | 5 | NIH | 2/10/2026 | $386,344 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R37CA233691 | Combinational Targeting the Feed-forward Epigenetic Circuitry in Mixed Lineage Leukemia | 000 | 7 | NIH | 2/5/2026 | -$334,571 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA303874 | Dissecting the Functional Role of PAX5 Mutations in B-cell Acute Lymphoblastic Leukemia | 001 | 1 | NIH | 1/27/2026 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | U01CA214254 | Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer | 000 | 8 | NIH | 2/6/2026 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA269569 | BAFF-R CAR T cell therapy for ALL | 000 | 4 | NIH | 1/28/2026 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA292596 | Anti-CD38 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Myelogenous Leukemia | 000 | 1 | NIH | 1/29/2026 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01HL156951 | Role of de novo pyrimidine biosynthesis in pathological cardiac remodeling | 000 | 4 | NIH | 2/3/2026 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA303874 | Dissecting the Functional Role of PAX5 Mutations in B-cell Acute Lymphoblastic Leukemia | 000 | 1 | NIH | 1/21/2026 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | UG1HL069278 | BMT CTN Core - City of Hope National Medical Center | 000 | 25 | NIH | 2/20/2026 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01DK143577 | Chromatin remodeling factors and mechanisms in diabetic microvascular complications | 000 | 1 | NIH | 12/22/2025 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA272678 | Randomized Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer | 001 | 4 | NIH | 3/11/2026 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01HL157539 | Role of the TET1 short isoform in MDS development and maintenance | 002 | 5 | NIH | 3/10/2026 | $371,790 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01DK129489 | The role of ALKBH5-mediated RNA demethylation in the maintenance of genomic stability in HSPCs | 001 | 5 | NIH | 2/27/2026 | $450,479 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA266659 | The Novel Role and Mechanism of RBM33 in Leukemogenesis | 001 | 5 | NIH | 3/20/2026 | $473,946 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | R01CA244866 | Exercise as Interception Therapy in Primary High Risk Cancer | 001 | 6 | NIH | 2/24/2026 | $0 |
| | 2026 | 2025 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010 | LOS ANGELES | USA | UM1CA186717 | Phase 1 and 2 Molecular and Clinical Pharmacodynamic Trials ETCTN | 000 | 9 | NIH | 2/27/2026 | $0 |
|
